Pennant Group Inc (PNTG) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Pennant Group Inc stock (PNTG) is currently trading at $31.02. Pennant Group Inc PE ratio is 37.35. Pennant Group Inc PS ratio (Price-to-Sales) is 1.15. Analyst consensus price target for PNTG is $37.83. WallStSmart rates PNTG as Hold.
- PNTG PE ratio analysis and historical PE chart
- PNTG PS ratio (Price-to-Sales) history and trend
- PNTG intrinsic value — DCF, Graham Number, EPV models
- PNTG stock price prediction 2025 2026 2027 2028 2029 2030
- PNTG fair value vs current price
- PNTG insider transactions and insider buying
- Is PNTG undervalued or overvalued?
- Pennant Group Inc financial analysis — revenue, earnings, cash flow
- PNTG Piotroski F-Score and Altman Z-Score
- PNTG analyst price target and Smart Rating
Pennant Group Inc
📊 No data available
Try selecting a different time range
PNTG Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Pennant Group Inc (PNTG)
PNTG appears undervalued based on the Graham Formula, trading 20% below its estimated fair value of $39.31.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Pennant Group Inc (PNTG) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, revenue growth, eps growth. Concerns around return on equity and operating margin. Fundamentals are solid but monitor weak areas for improvement.
Pennant Group Inc (PNTG) Key Strengths (4)
Revenue surging 53.20% year-over-year
Earnings per share surging 53.70% year-over-year
95.67% of shares held by major funds and institutions
Paying $1.15 for every $1 of annual revenue
Supporting Valuation Data
Pennant Group Inc (PNTG) Areas to Watch (6)
Very thin margins with limited operational efficiency
Very thin margins, barely profitable
Low profitability relative to shareholder equity
Premium pricing at 3.2x book value
Small-cap company with higher risk but more growth potential
Growth is fairly priced, not cheap, not expensive
Supporting Valuation Data
Pennant Group Inc (PNTG) Detailed Analysis Report
Overall Assessment
This company scores 59/100 in our Smart Analysis, earning a C grade. Out of 10 metrics analyzed, 4 register as strengths (avg 9.5/10) while 6 fall into concern territory (avg 3.7/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Revenue Growth, EPS Growth, Institutional Own.. Valuation metrics including Price/Sales (1.15) suggest the stock is attractively priced. Growth metrics are encouraging with Revenue Growth at 53.20%, EPS Growth at 53.70%.
The Bear Case
The primary concerns are Operating Margin, Profit Margin, Return on Equity. Some valuation metrics including PEG Ratio (1.81), Price/Book (3.23) suggest expensive pricing. Profitability pressure is visible in Return on Equity at 9.84%, Operating Margin at 6.25%, Profit Margin at 3.12%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Operating Margin improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 9.84% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 53.20% strong but requiring continuation.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Revenue Growth, EPS Growth) and negatives (Operating Margin, Profit Margin). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
PNTG Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
PNTG's Price-to-Sales ratio of 1.15x sits near its historical average of 1.21x (0th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 8% below its historical high of 1.25x set in Mar 2026, and 0% above its historical low of 1.15x in Mar 2026.
Compare PNTG with Competitors
Top MEDICAL CARE FACILITIES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Pennant Group Inc (PNTG) · HEALTHCARE › MEDICAL CARE FACILITIES
The Big Picture
Pennant Group Inc is a strong growth company balancing expansion with improving profitability. Revenue reached 948M with 53% growth year-over-year. Profit margins are strong at 312.0%, reflecting pricing power and operational efficiency.
Key Findings
Revenue growing at 53% YoY, reaching 948M. This pace significantly outperforms most MEDICAL CARE FACILITIES peers.
ROE of 984.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
What to Watch Next
Growth sustainability: can Pennant Group Inc maintain 53%+ revenue growth, or will competition slow it down?
Sector dynamics: monitor MEDICAL CARE FACILITIES industry trends, competitive moves, and regulatory changes that could impact Pennant Group Inc.
Bottom Line
Pennant Group Inc offers an attractive blend of growth (53% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Pennant Group Inc(PNTG)
NASDAQ
HEALTHCARE
MEDICAL CARE FACILITIES
USA
The Pennant Group, Inc. provides health care services in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company is headquartered in Eagle, Idaho.